Skip to content
Search

Latest Stories

July 2021 price concessions announced

The Pharmaceutical Services Negotiating Committee has released the list of Department of Health and Social Care-granted price concessions for July 2021.

DrugPack sizePrice Concession
Eplerenone 25mg tablets28£11.95
Eplerenone 50mg tablets28£15.53
Etoricoxib 60mg tablets28£6.00
Etoricoxib 90mg tablets28£8.35
Naftidrofuryl 100mg capsules84£7.84
Olmesartan medoxomil 20mg tablets28£6.44
Olmesartan medoxomil 40mg tablets28£10.35
Pregabalin 75mg capsules56£4.18
Sodium fluoride 0.05% mouthwash sugar free250ml£1.74
Sulfasalazine 500mg gastro-resistant tablets112£17.52
Sulfasalazine 500mg tablets112£16.50

Please note that a price concession only applies for the month in which it is granted.


No additional prescription endorsement are required as the new price is automatically applied by the NHSBSA to all items submitted for payment in the same month for which a price concession is granted.

More For You

national prescribing service for pharmacists

Sadik Al-Hassan MP

Sadik-Al-Hassan: National pharmacy prescribing service “entirely possible”

A national prescribing service for pharmacists could in theory be developed in the next two-three years according to Sadik-Al-Hassan MP.

Speaking at an event organised by PharmaTech in parliament on Wednesday, Hassan said community pharmacists had the skillset to prescribe but a national service would be “limited” by what they are currently allowed to do.

Keep ReadingShow less
First daily pill for endometriosis to be available on NHS

Instead of travelling to clinics for injections, endometriosis patients can take a daily tablet at home

Getty Images

New endometriosis pill approved for NHS use, but only few patients will benefit

The National Institute for Health and Care Excellence (NICE) has approved a new pill for the treatment of endometriosis, providing hope for thousands of women affected by the debilitating condition.

The pill, called relugolix–estradiol–norethisterone (also known as relugolix combination therapy or Ryeqo), is the first long-term daily pill approved for use in the UK to treat endometriosis, and it is expected to help about 1,000 patients every year.

Keep ReadingShow less
​RPS urges its members and fellows to vote in favour of Royal College for “a stronger, louder voice”

The Special Resolution Vote will remain open until 5 p.m. on Thursday, 24 March 2025.

Getty Images

Royal College voting begins: A historic moment in the profession’s evolution

Becoming a royal college will ensure pharmacy profession gains the recognition and authority it deserves, says RPS president Professor Claire Anderson.

Starting today (13), members and fellows of the Royal Pharmaceutical Society (RPS) will begin voting on the proposed changes to its Royal Charter, marking the beginning of a historic shift toward becoming the Royal College of Pharmacy.

Keep ReadingShow less
GPs to play crucial role in transforming Wales’ health service

Jeremy Miles

(Photo credit: www.gov.wales )

Strengthening GPs’ role key to transforming healthcare - Jeremy Miles

Welsh health secretary Jeremy Miles has recognised the need to transform health services and bring healthcare closer to home.

Speaking at the recent Welsh Local Medical Committees Conference, he emphasised that strengthening the role of GPs would be crucial in improving patient healthcare and tackling NHS waiting lists.

Keep ReadingShow less